Stocks and Investing Stocks and Investing
Mon, April 13, 2020

Matt Miksic Maintained (ABT) at Buy with Increased Target to $95 on, Apr 13th, 2020


Published on 2024-10-27 02:41:04 - WOPRAI, Matt Miksic
  Print publication without navigation


Matt Miksic of Credit Suisse, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $94 to $95 on, Apr 13th, 2020.

Matt has made no other calls on ABT in the last 4 months.



There are 11 other peers that have a rating on ABT. Out of the 11 peers that are also analyzing ABT, 4 agree with Matt's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Decreased Target to $93 on, Wednesday, April 8th, 2020
  • Amit Hazan of "Goldman Sachs" Initiated at Hold and Held Target at $96 on, Thursday, February 13th, 2020
  • Marie Thibault of "BTIG" Initiated at Hold on, Thursday, February 6th, 2020
  • Christopher Pasquale of "Guggenheim" Downgraded from Strong Buy to Hold on, Thursday, January 2nd, 2020


These are the ratings of the 7 analyists that currently disagree with Matt


  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $95 on, Thursday, April 9th, 2020
  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $92 on, Thursday, April 9th, 2020
  • David Lewis of "Morgan Stanley" Maintained at Buy with Decreased Target to $96 on, Friday, March 27th, 2020
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $87 on, Friday, March 27th, 2020
  • Joanna Wiensch of "Citigroup" Initiated at Strong Buy and Held Target at $96 on, Thursday, March 5th, 2020
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $105 on, Thursday, January 23rd, 2020
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $104 on, Thursday, January 23rd, 2020
Contributing Sources